Literature DB >> 2917004

'A'-esterases. Enzymes looking for a role?

M I Mackness1.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2917004     DOI： 10.1016/0006-2952(89)90376-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  14 in total

Review 1.  Paraoxonases as protective agents against N-acyl homoserine lactone - producing pathogenic microorganisms.

Authors:  Bogdan Nicolae Manolescu
Journal:  Maedica (Bucur)       Date:  2013-03

2.  The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns.

Authors:  M Antikainen; S Murtomäki; M Syvänne; R Pahlman; E Tahvanainen; M Jauhiainen; M H Frick; C Ehnholm
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

3.  Effect of some metallic cations and organic compounds on the O-hexyl O-2,5-dichlorophenyl phosphoramidate hydrolysing activity in hen plasma.

Authors:  M A Sogorb; N Díaz-Alejo; E Vilanova; J L Vicedo; V Carrera
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

4.  Nucleotide sequence of a novel arylesterase gene from Vibro mimicus and characterization of the enzyme expressed in Escherichia coli.

Authors:  J F Shaw; R C Chang; K H Chuang; Y T Yen; Y J Wang; F G Wang
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

5.  Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.

Authors:  Ayşe Yeşim Göçmen; Saadet Gümüşlü; Ender Semiz
Journal:  Clin Cardiol       Date:  2004-07       Impact factor: 2.882

6.  Paraoxonase activity in human pericardial fluid: its relationship to coronary artery disease.

Authors:  A F Hernandez; A Pla; A Valenzuela; F Gil; H P Hougen; E Villanueva
Journal:  Int J Legal Med       Date:  1993       Impact factor: 2.686

7.  Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations.

Authors:  M C Blatter Garin; C Abbott; S Messmer; M Mackness; P Durrington; D Pometta; R W James
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

Review 8.  Pharmacogenetics of paraoxonases: a brief review.

Authors:  D I Draganov; B N La Du
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-25       Impact factor: 3.000

9.  Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone.

Authors:  Graziella E Ronsein; Gissette Reyes-Soffer; Yi He; Michael Oda; Henry Ginsberg; Jay W Heinecke
Journal:  Mol Cell Proteomics       Date:  2015-12-14       Impact factor: 5.911

10.  Paraoxonase 1 (PON1) C/T-108 association with longitudinal mean arterial blood pressure.

Authors:  Vibha Bhatnagar; Lin Liu; Caroline M Nievergelt; Erin Richard; Victoria H Brophy; Braj Pandey; Michael S Lipkowitz; Daniel T O'Connor
Journal:  Am J Hypertens       Date:  2012-08-02       Impact factor: 2.689
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.